Webinar 2: Kits at consults: how healthcare providers can issue National Bowel Cancer Screening kits

This webinar explores how to issue National Bowel Cancer Screening Program kits to eligible patients in your practice. This ‘alternative access to kits model’ is in addition to the program’s mail-out model where kits are automatically mailed to eligible people. Learn about the benefits of engaging patients in population screening and discover effective methods for doing so. The webinar will cover how to use the National Cancer Screening Register to quickly bulk order kits and issue them to patients and the benefits of ongoing automatic screening reminders. This comprehensive session will equip healthcare providers with the tools and strategies to enhance patient care and increase bowel cancer screening in your community.

Learning Outcomes

At the completion of this webinar, you will be able to:  

• Outcome 1: Identify the rationale for, and the differences between, the program’s mail out model and the alternative access to kits model (healthcare provider issued kits)  

• Outcome 2: Identify the benefits of, and methods for engaging patients to participate in population screening via the alternative access to kits model  

• Outcome 3: Examine how to effectively use the NCSR to bulk order kits and issue them to patients  

• Outcome 4: Determine ways to change own practices to apply knowledge of the alternative access to kits model to help increase patient participation in population screening with the National Bowel Cancer Screening Program  

Presenter Information

Professor Vivienne Milch, Medical Director at Cancer Australia 

As Medical Director of Cancer Australia, I provide strategic clinical policy oversight and leadership to Cancer Australia, and advice to the Commonwealth Department of Health and Aged Care on national cancer screening policy.

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care. Our work includes the translation of evidence into policy and practice to advance patient-centred care; innovative and sustainable models of best practice cancer care and investment in priority areas of cancer research.  

I am passionate about the importance of early detection of cancer, equity of access to optimal cancer care, multidisciplinary survivorship care, and improving the lives of all Australians affected by cancer. 

Pre-webinar recommended learning   

• Core CPD Course: From kit to colonoscopy: navigating your patients through population bowel screening 

CPD

Educational activities: 1 hour